The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Krasnopolskaya K.V.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii;
kafedra akusherstva i ginekologii FUV MONIKI im. M.F. Vladimirskogo

Nazarenko T.A.

Kafedra akusherstva, ginekologii, perinatologii i reproduktologii fakul'teta poslediplomnogo professional'nogo obucheniia vracheĭ Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova;
Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova

Beketova A.N.

Moscow Regional Research Institute of Obstetrics and Gynecology, Ministry of Health of the Moscow Region, Moscow, Russia;
International Clinic «Family», Moscow, Russia

Ivakhnenko V.N.

Otdelenie reproduktsii Moskovskogo oblastnogo NII akusherstva i ginekologii

The influence of Pergoveris and high starting dose of rFSH on IVF efficiency in patients with high risk of poor respond

Authors:

Krasnopolskaya K.V., Nazarenko T.A., Beketova A.N., Ivakhnenko V.N.

More about the authors

Read: 10533 times


To cite this article:

Krasnopolskaya KV, Nazarenko TA, Beketova AN, Ivakhnenko VN. The influence of Pergoveris and high starting dose of rFSH on IVF efficiency in patients with high risk of poor respond. Russian Journal of Human Reproduction. 2013;(3):37‑42. (In Russ.)

Recommended articles:
The Pate­rnity Test. Russian Journal of Human Reproduction. 2025;(4):41-45
Endo­metriosis-associated infe­rtility and the effi­cacy of dienogest. Russian Journal of Human Reproduction. 2025;(5):58-63

References:

  1. Ludwig M., Felberbaum R.E., Diedrich K., Lunenfeld B. Ovarian stimulation: from basic science to clinical application. Reprod Biomed Online 2002; 5: Suppl 1: 73-86.
  2. Ferraretti A.P., Gianaroli L., Magli M. et al. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil Steril 2004; 82: 6: 1521-1526.
  3. Ferraretti A.P., Feliciani E., Tabanelli C. et al. LH pre-treatment as strategy for repeated young poor ovarian responders. Hum Reprod 2012; 27: Suppl 1: Abstract Book; O-280: i.109-i110.
  4. Bosch E., Labarta E., Crespo J. et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod 2010; 25: 2092-2100.
  5. Bourgain C., Devroey P. The endometrium in stimulated cycles for IVF. Hum Reprod Update 2003; 9: 515-522.
  6. Alviggi C., Humaidan P., Howles C.M. et al. Biological versus chronological ovarian age: implications for assisted reproductive technology. Reprod Biol Endocrinol 2009; 22: 101-113.
  7. Kailasam C., Keay S.D., Wilson P. et al. Defining poor ovarian response during IVF cycles in women aged <40 years and its relationship with treatment outcome. Hum Reprod 2004; 19: 1544-1547.
  8. Nyboe A.A., Humaidan P., Fried G. et al. Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in vitro fertilization. A multicentre, prospective, randomized, controlled trial. Hum Reprod 2008; 23: 427-434.
  9. Matorras R., Prieto B., Exposito A. et al. Mid-follicular LH supplementation in women 35-39 years undergoing ICSI cycles: a randomized controlled study. Reprod Biomed Online 2009; 19: 879-887.
  10. Ruiz Balda J.A., Caballero J.L., Roque A., Ezcurra D. Clinical experience with Pergoveris, a new formulation of rFSH and rLH in a 2:1 ratio, for treatment of suboptimal patient populations: Spanish preliminary results. Fertil Steril 2009; 92: Suppl: S163.
  11. Mochtar M.H., Van der Veen F., Ziech M., van Wely M. Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database Syst Rev 2007; 2: CD005070.
  12. Filicori M., Cognigni G.E., Tabarelli C. et al. Stimulation and growth of antral ovarian follicles by selective LH activity administration in women. J Clin Endocrinol Metabol 2002; 87: 1156-1161.
  13. Barbieri R.L., Sluss P.M., Powers R.D. et al. Association of body mass index, age, and cigarette smoking with serum testosterone levels in cycling women undergoing in vitro fertilization. Fertil Steril 2005; 83: 302-308.
  14. Simoni M., Nieschlag E., Gromoll J. Isoforms and single nucleotide polymorphisms of FSH receptor gene: implications for human reproduction. Hum Reprod Update 2002; 8: 413-421.
  15. Alviggi C., Clarizia R., Pettersson K. et al. Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism. Reprod Biomed Online 2009; 18: 9-14.
  16. McKenzie L.J., Pangas S.A., Carson S.A. et al. Human cumulus granulose cell gene expression: a predictor of fertilization and embryo selection in women undergoing IVF. Hum Reprod 2004; 19: 2869-2874.
  17. Ruvolo G., Bosco L., Pane A. et al. Lover apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedure. Fertil Steril 2007; 87: 542-546.
  18. Palermo R. Differential actions of FSH and LH during folliculogenesis. Reprod Biomed Online 2007; 15: 326-337.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.